• Medientyp: E-Artikel
  • Titel: Autonomous Cortisol Secretion Influences Psychopathological Symptoms in Patients With Primary Aldosteronism
  • Beteiligte: Gendreitzig, Pauline; Künzel, Heike E; Adolf, Christian; Handgriff, Laura; Müller, Lisa; Holler, Finn; Sturm, Lisa; Heinrich, Daniel A; Reincke, Martin; Quinkler, Marcus
  • Erschienen: The Endocrine Society, 2021
  • Erschienen in: The Journal of Clinical Endocrinology & Metabolism
  • Sprache: Englisch
  • DOI: 10.1210/clinem/dgab099
  • ISSN: 0021-972X; 1945-7197
  • Schlagwörter: Biochemistry (medical) ; Clinical Biochemistry ; Endocrinology ; Biochemistry ; Endocrinology, Diabetes and Metabolism
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Context</jats:title> <jats:p>Primary aldosteronism (PA) is associated with impaired quality of life (QoL). Autonomous cortisol cosecretion (ACS) is a relevant phenotype of PA, which could contribute to depression and anxiety disorders. This has not been investigated so far.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective</jats:title> <jats:p>To evaluate the prevalence of depression and anxiety in PA patients according to ACS.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We performed testing for hypercortisolism and evaluated anxiety, depression and QoL by self-rating questionnaires in newly diagnosed PA patients of the German Conn’s Registry; 298 patients were reevaluated at follow-up.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In the overall cohort, scores for anxiety (P &amp;lt; .001), depression (P &amp;lt; .001), and QoL (mental P = .021; physical P = .015) improved significantly at follow-up. This improvement was seen in both subgroups of patients with and without ACS, with the exception of the mental subscore in no-ACS patients. Analysis for sex differences showed that anxiety decreased significantly in females with ACS and no-ACS, whereas males with no-ACS failed to improve. Depression improved significantly in males and females with ACS (P = .004, P = 0.011 respectively), but not in those with no-ACS. Physical subscore of QoL improved significantly (P = .023) in females with ACS and mental subscore (P = .027) in males with ACS, whereas no differences were seen for the no-ACS groups.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Improvement in depression and anxiety scores in response to treatment of PA is more pronounced in patients with ACS in contrast to no-ACS suggesting a role of ACS in the psychopathological symptoms of patients with PA. Furthermore, we observed significant differences in depression and anxiety scores between the sexes.</jats:p> </jats:sec>
  • Zugangsstatus: Freier Zugang